Literature DB >> 16946933

Chronic cognitive impairment in users of 'ecstasy' and cannabis.

Anthony Klugman1, John Gruzelier.   

Abstract

MDMA use is commonly accompanied by use of other substances, most notably cannabis. Both MDMA and cannabis have probable effects on cognition. This paper reviews research into long-term effects on cognition which are likely to represent neurotoxicity. Research is hampered by numerous confounds and methodological difficulties. With recent cannabis use there is both an acute and a residual effect on cognition, making it important to have a significant abstinence period from cannabis when studying effects of MDMA in recreational users of both substances. It would appear that MDMA does indeed have subtle long-term effects on complex memory and executive functions that are independent of cannabis and may remain with abstention. This is consistent with evidence of disruption of the serotonin system in animal and human studies. Chronic effects on cognition due to cannabis are less consistently demonstrated, but more sensitive tests including electrophysiological measures have revealed long-term deficits in attention.

Entities:  

Year:  2003        PMID: 16946933      PMCID: PMC1525102     

Source DB:  PubMed          Journal:  World Psychiatry        ISSN: 1723-8617            Impact factor:   49.548


  46 in total

1.  Neuropsychological performance in long-term cannabis users.

Authors:  H G Pope; A J Gruber; J I Hudson; M A Huestis; D Yurgelun-Todd
Journal:  Arch Gen Psychiatry       Date:  2001-10

2.  Auditory verbal learning in drug-free Ecstasy polydrug users.

Authors:  H. C. Fox; A. S. Toplis; J. J. D. Turner; A. C. Parrott
Journal:  Hum Psychopharmacol       Date:  2001-12       Impact factor: 1.672

3.  Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits.

Authors:  A C Parrott; A Lees; N J Garnham; M Jones; K Wesnes
Journal:  J Psychopharmacol       Date:  1998       Impact factor: 4.153

4.  The content of ecstasy tablets: implications for the study of their long-term effects.

Authors:  Jon C Cole; Mike Bailey; Harry R Sumnall; Graham F Wagstaff; Les A King
Journal:  Addiction       Date:  2002-12       Impact factor: 6.526

5.  Cognitive performance and serotonergic function in users of ecstasy.

Authors:  R J Verkes; H J Gijsman; M S Pieters; R C Schoemaker; S de Visser; M Kuijpers; E J Pennings; D de Bruin; G Van de Wijngaart; J M Van Gerven; A F Cohen
Journal:  Psychopharmacology (Berl)       Date:  2001-01-01       Impact factor: 4.530

6.  Effects of chronic marijuana use on human cognition.

Authors:  R I Block; M M Ghoneim
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Short-term memory impairment in cannabis-dependent adolescents.

Authors:  R H Schwartz; P J Gruenewald; M Klitzner; P Fedio
Journal:  Am J Dis Child       Date:  1989-10

Review 8.  Health consequences of acute and chronic marihuana use.

Authors:  M O Maykut
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1985       Impact factor: 5.067

9.  Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.

Authors:  M J Morgan
Journal:  Neuropsychopharmacology       Date:  1998-10       Impact factor: 7.853

10.  Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function?

Authors:  J H Krystal; L H Price; C Opsahl; G A Ricaurte; G R Heninger
Journal:  Am J Drug Alcohol Abuse       Date:  1992       Impact factor: 3.829

View more
  6 in total

1.  (+/-)-3,4-Methylenedioxymethamphetamine treatment in adult rats impairs path integration learning: a comparison of single vs once per week treatment for 5 weeks.

Authors:  Matthew R Skelton; Jessica A Able; Curtis E Grace; Nicole R Herring; Tori L Schaefer; Gary A Gudelsky; Charles V Vorhees; Michael T Williams
Journal:  Neuropharmacology       Date:  2008-07-12       Impact factor: 5.250

Review 2.  Developmental effects of 3,4-methylenedioxymethamphetamine: a review.

Authors:  Matthew R Skelton; Michael T Williams; Charles V Vorhees
Journal:  Behav Pharmacol       Date:  2008-03       Impact factor: 2.293

3.  Hallucinogen use disorders among adult users of MDMA and other hallucinogens.

Authors:  Li-Tzy Wu; Christopher L Ringwalt; Paolo Mannelli; Ashwin A Patkar
Journal:  Am J Addict       Date:  2008 Sep-Oct

Review 4.  Bidirectional causality between addiction and cognitive deficits.

Authors:  Patrick R Melugin; Suzanne O Nolan; Cody A Siciliano
Journal:  Int Rev Neurobiol       Date:  2020-12-30       Impact factor: 3.230

5.  Depression, lifestyle factors and cognitive function in people living with HIV and comparable HIV-negative controls.

Authors:  D De Francesco; J Underwood; E Bagkeris; M Boffito; F A Post; Pwg Mallon; J H Vera; I Williams; J Anderson; M Johnson; C A Sabin; A Winston
Journal:  HIV Med       Date:  2019-02-08       Impact factor: 3.180

Review 6.  Cannabinoids in health and disease.

Authors:  Natalya M Kogan; Raphael Mechoulam
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.